These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31724832)

  • 21. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
    Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR
    J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1.
    Albini E; Coletti A; Greco F; Pallotta MT; Mondanelli G; Gargaro M; Belladonna ML; Volpi C; Bianchi R; Grohmann U; Macchiarulo A; Orabona C
    Biochem Pharmacol; 2018 Dec; 158():286-297. PubMed ID: 30391205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
    Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
    Sari S; Tomek P; Leung E; Reynisson J
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors.
    Lancellotti S; Novarese L; De Cristofaro R
    Curr Med Chem; 2011; 18(15):2205-14. PubMed ID: 21517759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylene blue and ascorbate interfere with the accurate determination of the kinetic properties of IDO2.
    Yuasa HJ; Stocker R
    FEBS J; 2021 Aug; 288(16):4892-4904. PubMed ID: 33686747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand and substrate migration in human indoleamine 2,3-dioxygenase.
    Nickel E; Nienhaus K; Lu C; Yeh SR; Nienhaus GU
    J Biol Chem; 2009 Nov; 284(46):31548-54. PubMed ID: 19767648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Study of a Flexible Active Site Loop in Human Indoleamine 2,3-Dioxygenase and Its Functional Implications.
    Álvarez L; Lewis-Ballester A; Roitberg A; Estrin DA; Yeh SR; Marti MA; Capece L
    Biochemistry; 2016 May; 55(19):2785-93. PubMed ID: 27112409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trial watch: IDO inhibitors in cancer therapy.
    Le Naour J; Galluzzi L; Zitvogel L; Kroemer G; Vacchelli E
    Oncoimmunology; 2020 Jun; 9(1):1777625. PubMed ID: 32934882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
    Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition Mechanisms of Human Indoleamine 2,3 Dioxygenase 1.
    Lewis-Ballester A; Karkashon S; Batabyal D; Poulos TL; Yeh SR
    J Am Chem Soc; 2018 Jul; 140(27):8518-8525. PubMed ID: 29897749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive comparison of the metazoan tryptophan degrading enzymes.
    Yuasa HJ
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140247. PubMed ID: 31276825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic Implications.
    Liu G; Chen S; Zhong J; Teng K; Yin Y
    Oxid Med Cell Longev; 2017; 2017():1602074. PubMed ID: 28377795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of indoleamine-2,3-dioxigenase 1 inhibitory activity of 4,6-disubstituted indazole derivatives and their heme binding affinity.
    Tsujino H; Uno T; Yamashita T; Katsuda M; Takada K; Saiki T; Maeda S; Takagi A; Masuda S; Kawano Y; Meguro K; Akai S
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126607. PubMed ID: 31431359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenase.
    Lewis-Ballester A; Forouhar F; Kim SM; Lew S; Wang Y; Karkashon S; Seetharaman J; Batabyal D; Chiang BY; Hussain M; Correia MA; Yeh SR; Tong L
    Sci Rep; 2016 Oct; 6():35169. PubMed ID: 27762317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The therapeutic potential of targeting tryptophan catabolism in cancer.
    Opitz CA; Somarribas Patterson LF; Mohapatra SR; Dewi DL; Sadik A; Platten M; Trump S
    Br J Cancer; 2020 Jan; 122(1):30-44. PubMed ID: 31819194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*.
    Ortiz-Meoz RF; Wang L; Matico R; Rutkowska-Klute A; De la Rosa M; Bedard S; Midgett R; Strohmer K; Thomson D; Zhang C; Mebrahtu M; Guss J; Totoritis R; Consler T; Campobasso N; Taylor D; Lewis T; Weaver K; Muelbaier M; Seal J; Dunham R; Kazmierski W; Favre D; Bergamini G; Shewchuk L; Rendina A; Zhang G
    Chembiochem; 2021 Feb; 22(3):516-522. PubMed ID: 32974990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme.
    Pallotta MT; Rossini S; Suvieri C; Coletti A; Orabona C; Macchiarulo A; Volpi C; Grohmann U
    FEBS J; 2022 Oct; 289(20):6099-6118. PubMed ID: 34145969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human indoleamine-2,3-dioxygenase 2 cofactor lability and low substrate affinity explained by homology modeling, molecular dynamics and molecular docking.
    Mirgaux M; Leherte L; Wouters J
    J Biomol Struct Dyn; 2024 Jun; 42(9):4475-4488. PubMed ID: 37301605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Indoleamine 2,3-Dioxygenase 1 Is an Efficient Mammalian Nitrite Reductase.
    Lim YJ; Foo TC; Yeung AWS; Tu X; Ma Y; Hawkins CL; Witting PK; Jameson GNL; Terentis AC; Thomas SR
    Biochemistry; 2019 Feb; 58(7):974-986. PubMed ID: 30585477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.